Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow 0.00% Nasdaq Up0.52%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
7.50 Down 0.09(1.19%) 4:00PM EDT
|After Hours : 7.45 Down 0.05 (0.67%) 5:19PM EDT
Get the big picture on all your investments.
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.4
Mean Recommendation (last week):2.6
Change:-0.2

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:14.92
Median Target:14.50
High Target:24.00
Low Target:4.50
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Aug 2, 2013BarclaysDowngradeOverweightEqual Weight
Apr 1, 2011Stifel NicolausInitiated Buy
Oct 19, 2010JMP SecuritiesInitiated Mkt Perform
Oct 6, 2010Barclays CapitalInitiated Overweight
Apr 8, 2010William BlairInitiated Outperform
Mar 22, 2010Brean MurrayUpgradeHoldBuy
Oct 13, 2009Wedbush MorganUpgradeNeutralOutperform
Apr 29, 2009Roth CapitalUpgradeHoldBuy
Apr 21, 2009Wedbush MorganInitiated Buy
Mar 20, 2009LazardInitiated Hold

More Upgrades & Downgrades for HALO

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy2111
Buy3333
Hold2233
Underperform0000
Sell1111

Data provided by Thomson/First Call


Currency in USD.